We align with the Endocrine Society and the Obesity Medicine Association's recommendations to exercise caution with compounded formulations, as they are not FDA-approved and the uncertainty regarding their sterility
Why did CVS Caremark stop covering Zepbound
This has led to the advent of dual agonists, i.e., agents that co-activate the GLP-1R and one more receptor at the same time (e.g., GLP-1R/GIPR co-agonists, GLP-1R/AMYR co-agonists), and of triple unimolecular agonists, activating two more receptors in addition to the GLP-1R simultaneously (e.g., GLP-1R/GIPR/GCGR co-agonists) [1]
Time zones Mexico uses three different time zones, so it is wise to assess the time difference of your destination before landing to assess your medication plan
The short answer is that there are no known direct pharmacological interactions between GLP-1 receptor agonists and estrogen or progesterone therapy